Development and validation of a novel diagnostic nomogram model to predict primary aldosteronism in patients with hypertension.

We have developed a novel nomogram to predict PA in hypertensive individuals based on routine biochemical variables. External validation is needed to further demonstrate its predictive ability in primary care settings.